Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Ettinger, DS; Wood, DE; Stevenson, J; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; DeCamp, M; Dowell, J ...
Published in: J Natl Compr Canc Netw
September 2023
Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term "malignant" is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
September 2023
Volume
21
Issue
9
Start / End Page
961 / 979
Location
United States
Related Subject Headings
- Peritoneum
- Oncology & Carcinogenesis
- Mesothelioma, Malignant
- Mesothelioma
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Wood, D. E., Stevenson, J., Aisner, D. L., Akerley, W., Bauman, J. R., … Hughes, M. (2023). Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 21(9), 961–979. https://doi.org/10.6004/jnccn.2023.0045
Ettinger, David S., Douglas E. Wood, James Stevenson, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, et al. “Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 21, no. 9 (September 2023): 961–79. https://doi.org/10.6004/jnccn.2023.0045.
Ettinger DS, Wood DE, Stevenson J, Aisner DL, Akerley W, Bauman JR, et al. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Sep;21(9):961–79.
Ettinger, David S., et al. “Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 21, no. 9, Sept. 2023, pp. 961–79. Pubmed, doi:10.6004/jnccn.2023.0045.
Ettinger DS, Wood DE, Stevenson J, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Otterson GA, Patel SP, Patil T, Polanco PM, Riely GJ, Riess J, Shapiro TA, Singh AP, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hughes M. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Sep;21(9):961–979.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
September 2023
Volume
21
Issue
9
Start / End Page
961 / 979
Location
United States
Related Subject Headings
- Peritoneum
- Oncology & Carcinogenesis
- Mesothelioma, Malignant
- Mesothelioma
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis